Skip to main content

Table 5 Construct validity for frequency of headaches, MIDAS, and PH9 categorical scores

From: Development of a self-reporting questionnaire, BURMIG, to evaluate the burden of migraine

 

Whole population sample

Healthy subjects

Primary care

Pain clinic

General population sample

All

Chi square

General population sample

All

Chi Square

N mean (days/month of headaches)

 Less than 1 day

0 (0%)

0 (0%)

2 (2.15%)

2

 

1 (4.55%)

1

 

 1–3 days

5 (29.41%)

6 (30%)

20 (21.51%)

31

 

7 (31.82%)

18

 

 4–9 days

6 (35.29%)

2 (10%)

42 (45.16%)

50

 

9 (40.91%)

17

 

 10–14 days

3 (17.65%)

3 (15%)

18 (19.35%)

24

 

4 (18.18%)

10

 

 >15 days

3 (17.65%)

9 (45%)

11 (11.83%)

23

 

1 (4.55%)

13

 

 Total

17 (13.08%)

20 (15.38%)

93 (71.54%)

130

 0.0238

22 (37.29%)

59

 0.0629

MIDAS score

 Minimal or infrequent disability

3 (23.08%)

4 (23.53%)

14 (19.44%)

21

 

9 (47.37%)

16

 

 Mild or infrequent disability

0 (0%)

0 (0%)

10 (13.89%)

10

 

5 (26.32%)

5

 

 Moderate disability

6 (46.15%)

2 (11.76%)

18 (25%)

26

 

4 (21.05%)

12

 

 Severe disability

4 (30.77%)

11 (64.71%)

30 (41.67%)

45

 

1 (5.26%)

16

 

 Total

13 (12.75%)

17 (16.67%)

72 (70.59%)

102

 0.159

19 (38.78%)

49

0.0005

Depressive disorder

 No

14 (82.35%)

17 (85%)

86 (92.47%)

117

 

22 (100%)

53

 

 Yes

3 (17.65%)

3 (15%)

7 (7.53%)

13

 

0 (0%)

6

 

 Total

17 (13.08%)

20 (15.38%)

93 (71.54%)

130

 0.3179

22 (37.29%)

59

 
  1. Headache days, the MIDAS score as a measure of disability and the presence of depression are detailed for the different samples of participants according to their origin. On the right hand side of the table, the subset of healthy participants (without headache) in the generation population sample, is detailed